A detailed history of Pathstone Holdings, LLC transactions in Grifols Sa stock. As of the latest transaction made, Pathstone Holdings, LLC holds 76,570 shares of GRFS stock, worth $696,021. This represents 0.0% of its overall portfolio holdings.

Number of Shares
76,570
Previous 83,190 7.96%
Holding current value
$696,021
Previous $524,000 29.58%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$6.28 - $9.38 $41,573 - $62,095
-6,620 Reduced 7.96%
76,570 $679,000
Q2 2024

Aug 14, 2024

SELL
$6.27 - $7.7 $51,514 - $63,263
-8,216 Reduced 8.99%
83,190 $524,000
Q1 2024

May 13, 2024

BUY
$5.47 - $11.38 $426,523 - $887,355
77,975 Added 580.56%
91,406 $610,000
Q4 2023

Feb 14, 2024

BUY
$7.71 - $11.56 $103,553 - $155,262
13,431 New
13,431 $155,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $6.17B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.